MAP Congress 2019: Interpreting molecular alterations for clinical practice
This item is under embargo and is only visible to journalists
Please login here
Regions: Europe, Switzerland, United Kingdom
Keywords: Science, Life Sciences, Public Dialogue - science, Business, Medical & pharmaceutical, Health, Medical
The item has been withdrawn. If you are a journalists please contact the person that posted the item with any questions.